Clinical Trial Update: HKT-500 in Adult Patients With Ankle Sprain [Phase 3]

View source ↗

Summary

Phase 3 trial of HKT-500 in adults with ankle sprain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankle Sprain

Drugs mentioned

• HKT-500

Snippet

Sponsor: Hisamitsu Pharmaceutical Co., Inc. | Conditions: Ankle Sprain | Phase 3 | Status: COMPLETED